Tools

LEADER 03617cam a2200613 i 4500

001 on1579072155;

005 20260316085613.0;

006 m o d f ;

007 cr bn||||a||||;

008 260312s2026 dcua ob f000 0 eng c;

024 8 a| 60-330q| (GPO jacket number);

035 a| (Sirsi) o1579072155;

035 a| (OCoLC)1579072155;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 1019-C-01 (online);

086 0 a| Y 4.C 73/8:117-77;

088 a| Serial no. 117-77 (United States. Congress. House. Committee on Energy and Commerce);

245 10 a| FDA user fee reauthorization :b| ensuring safe and effective medical devices : hybrid hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventeenth Congress, second session, March 30, 2022.;

246 30 a| Ensuring safe and effective medical devices;

246 3 a| Food and Drug Administration user fee reauthorization;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2026.;

300 a| 1 online resource (v, 123 pages) :b| color illistrations;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| This is a publication issued by the United States federal government or produced with federal funds.;

500 a| Associated bill citation(s): H.R. 7084; H.R. 7192.;

500 a| "Serial no. 117-77.";

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Jeff Shuren, M.D., Director, Center for Devices and Radiological Health, Food and Drug Administration; Richard J. Kovacs, M.D., Q.E. and Sally Russell Professor of Medicine, Indiana University School of Medicine, Chief Medical Officer, American College of Cardiology; Mark Leahey, President and CEO, Medical Device Manufacturers Association; Janet Trunzo, Senior Executive Vice President, Technology And Regulatory Affairs, Advanced Medical Technology Association; Diane Wurzburger, Executive of Regulatory Affairs, GE Healthcare.;

518 a| Date of hearing: 2022-03-30.;

588 a| Description based on online resource, PDF version; title from title page (GovInfo, viewed Mar. 12, 2026).;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

610 10 a| United States.b| Food and Drug Administration.=| ^A1253;

650 0 a| User chargesz| United States.=| ^A420592;

650 0 a| Drug approvalz| United States.=| ^A1001108;

650 0 a| Medical suppliesx| Certificationz| United States.=| ^A450443;

650 7 a| Health.2| cgpa;

650 7 a| Commerce.2| cgpa;

655 7 a| Legislative hearings.2| lcgft;

776 08 i| Print version:a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.t| FDA user fee reauthorizationw| (OCoLC)1579076699;

856 40 u| https://purl.fdlp.gov/GPO/gpo2538767| 0;

856 4 z| Address at time of PURL creationu| https://www.govinfo.gov/content/pkg/CHRG-117hhrg60330/pdf/CHRG-117hhrg60330.pdf;

949 a| Click on web addressw| asish| joyner94o| jjlm;

994 a| C0b| GPO;

955 a| bca68 20260312b| 20260312;

922 a| BIBCONEWb| 20260312;

596 a| 1;

998 a| 6722876;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6722876-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 4/28/2026x| EDOCUMENTz| JERESOURCEo| .STAFF. jjlm;

FDA user fee reauthorization : ensuring safe and effective medical devices : hybrid hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventeenth Congress, second session, March 30, 2022.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2026.
Description	1 online resource (v, 123 pages) : color illistrations
Supplemental Content	https://purl.fdlp.gov/GPO/gpo253876
Supplemental Content	Address at time of PURL creation
Subjects	United States. Food and Drug Administration. User charges--United States. Drug approval--United States. Medical supplies--Certification. --United States.

Portion of title	Ensuring safe and effective medical devices
Variant title	Food and Drug Administration user fee reauthorization
General note	This is a publication issued by the United States federal government or produced with federal funds.
General note	Associated bill citation(s): H.R. 7084; H.R. 7192.
General note	"Serial no. 117-77."
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Jeff Shuren, M.D., Director, Center for Devices and Radiological Health, Food and Drug Administration; Richard J. Kovacs, M.D., Q.E. and Sally Russell Professor of Medicine, Indiana University School of Medicine, Chief Medical Officer, American College of Cardiology; Mark Leahey, President and CEO, Medical Device Manufacturers Association; Janet Trunzo, Senior Executive Vice President, Technology And Regulatory Affairs, Advanced Medical Technology Association; Diane Wurzburger, Executive of Regulatory Affairs, GE Healthcare.
Date/time/place of a event note	Date of hearing: 2022-03-30.
Source of description	Description based on online resource, PDF version; title from title page (GovInfo, viewed Mar. 12, 2026).
Issued in other form	Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. FDA user fee reauthorization
Genre/form	Legislative hearings.
Standard identifier#	60-330 (GPO jacket number)
Technical rpt number	Serial no. 117-77 (United States. Congress. House. Committee on Energy and Commerce)
GPO item number	1019-C-01 (online)
Govt. docs number	Y 4.C 73/8:117-77

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Online Content https://purl.fdlp.gov/GPO/gpo253876 Address at time of PURL creation	✔ Available

FDA user fee reauthorization : ensuring safe and effective medical devices : hybrid hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventeenth Congress, second session, March 30, 2022.

Click here for more information about this title

Availability